Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Special Drug Use Surveillance of EFIENT Tablet - Prasugrel For Japanese patients with ischemic heart disease in long-term use clinical practice -

Next Previous
Trial Profile

Special Drug Use Surveillance of EFIENT Tablet - Prasugrel For Japanese patients with ischemic heart disease in long-term use clinical practice -

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Prasugrel (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Angina pectoris; Ischaemia; Ischaemic heart disorders; Myocardial infarction; Stroke; Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PRASFIT-Practice II
  • Sponsors Daiichi Sankyo Company

    • Most Recent Events

    • 02 Oct 2020 Final two-year follow-up results published in the Circulation Journal.
    • 12 Nov 2019 Results of one year follow up study assessing effectiveness and safety of prasugrel were published in the Circulation Journal
    • 24 Jan 2019 Results of interim analysis of data from case report forms (CRFs) after 3 months published in the Circulation Journal
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top